Corporate Banner
Satellite Banner
Proteomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

New LC Column Line for Protein Separations

Published: Monday, January 28, 2013
Last Updated: Monday, January 28, 2013
Bookmark and Share
Company introduces Amplus® wide-pore core shell HPLC columns at ASMS Sanibel Conference.

Protea Biosciences Group, Inc. has announced at the ASMS Sanibel Conference the introduction of Amplus® wide-pore core shell HPLC columns, a new line of liquid chromatography columns specifically designed for intact proteins analysis.

This new family of HPLC silica-based columns employ core shell technology combined with a specific porosity designed to facilitate proteins separation, including those with high molecular weight.

“This year the ASMS Sanibel Conference is focused on Top Down proteomics applications and we thought it was a great opportunity to introduce a new technology designed for intact protein chromatographic analysis,” stated Alessandro Baldi, PhD, Vice President and General Manager of Protea Biosciences.

Baldi continued, ‘Amplus’ technology provides scientists with high chromatographic efficiency and facilitates Top Down proteomics approach to study intact proteins with or without mass spectrometry.”

Amplus, the new brand of analytical columns, has been developed in collaboration with the Japanese firm CromaNik Technologies and it is available in different chemistries and porosities to facilitate and resolve the most difficult separations in Top Down proteomics studies.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Protea, Protein Metrics Collaboration to Focus on Biotherapeutics
Companies collaborate to advance new analytical capabilities for use in the development of protein biotherapeutics.
Monday, February 22, 2016
Scientific News
Untangling Disease-Related Protein Misfolding
Work advances understanding of genetic forms of thrombosis, emphysema, cirrhosis of the liver, neurodegenerative diseases and inflammation, among others.
Scientists Find Evidence That Cancer Can Arise Changes
Researchers at Rockefeller University have found a mutation that affects the proteins that package DNA without changing the DNA itself can cause a rare form of cancer.
US-India Collab Finds Molecular Signatures of Severe Malaria
Study may be a significant advancement in understanding the causes of severe malaria.
Triple-Negative Breast Cancer Target Is Found
Researchers at UC Berkeley discover a target that drives cancer metabolism in triple-negative breast cancer.
Crucial Reaction for Vision Revealed
Scientists have tracked the reaction of a protein responding to light, paving the way for a new understanding of life's essential reactions.
Cancer Can Arise from Histone Mutations
A mutation that affects the proteins that package DNA—without changing the DNA itself—can cause a rare form of cancer.
Mimicking Evolution to Create Novel Proteins
A study by researchers in the Kuhlman lab offers a new route to design the 'cellular machines' needed to understand and battle diseases.
Can Gender Play A Role In Determining Cancer Treatment Choices?
MD Anderson study reveals “sex-biased” gene signatures in review of 13 cancer types.
New Autism Blood Biomarker Identified
Researchers at UT Southwestern Medical Center have identified a blood biomarker that may aid in earlier diagnosis of children with autism spectrum disorder, or ASD.
FNIH Launches Project to Evaluate Biomarkers in Cancer Patients
Company has announced that it has launched a new project to evaluate the effectiveness of liquid biopsies as biomarkers in colorectal cancer patients.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!